Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

Assess Safety and Efficacy of VAD044 in HHT Patients

NCT05406362

Conditions
Arteriovenous Malformations, Cardiovascular Abnormalities, Cardiovascular Diseases, +11 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Hospices Civils de Lyon Lyon, France
  • Ospedale Maggiore di Crema Crema, Italy
View Trial Details
Active, Not Recruiting

Minimal Residual Disease-based Strategy With T-Cell Redirector After Treatment With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma

NCT06353022

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • CH de la Côte Basque Bayonne, France
  • CHU Caen Caen, France
  • CHRU DIjon Dijon, France
  • Chd Vendee La Roche-sur-Yon, France
View all 19 locations
View Trial Details
Active, Not Recruiting

A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)

NCT05624554

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Highlands Oncology Group ( Site 5205) Springdale, Arkansas, United States
  • Clermont Oncology Center ( Site 5224) Clermont, Florida, United States
  • Hattiesburg Clinic Hematology/Oncology ( Site 5216) Hattiesburg, Mississippi, United States
  • Medical Oncology Associates, PS ( Site 5206) Spokane, Washington, United States
View all 97 locations
View Trial Details
Active, Not Recruiting

A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM

NCT02886065

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Weill Cornell Medical College New York, United States
View Trial Details
Active, Not Recruiting

An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study

NCT05364086

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
Locations
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
  • Kaiser Permanente-Baldwin Park Baldwin Park, California, United States
View all 259 locations
View Trial Details

Related conditions